1. Home
  2. ATHA vs AITR Comparison

ATHA vs AITR Comparison

Compare ATHA & AITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHA
  • AITR
  • Stock Information
  • Founded
  • ATHA 2011
  • AITR 2022
  • Country
  • ATHA United States
  • AITR United States
  • Employees
  • ATHA N/A
  • AITR N/A
  • Industry
  • ATHA Medicinal Chemicals and Botanical Products
  • AITR
  • Sector
  • ATHA Health Care
  • AITR
  • Exchange
  • ATHA Nasdaq
  • AITR Nasdaq
  • Market Cap
  • ATHA 93.5M
  • AITR 83.1M
  • IPO Year
  • ATHA 2020
  • AITR 2023
  • Fundamental
  • Price
  • ATHA $0.67
  • AITR $10.60
  • Analyst Decision
  • ATHA Buy
  • AITR
  • Analyst Count
  • ATHA 4
  • AITR 0
  • Target Price
  • ATHA $11.25
  • AITR N/A
  • AVG Volume (30 Days)
  • ATHA 14.2M
  • AITR 57.8K
  • Earning Date
  • ATHA 11-07-2024
  • AITR 01-01-0001
  • Dividend Yield
  • ATHA N/A
  • AITR N/A
  • EPS Growth
  • ATHA N/A
  • AITR N/A
  • EPS
  • ATHA N/A
  • AITR 0.24
  • Revenue
  • ATHA N/A
  • AITR N/A
  • Revenue This Year
  • ATHA N/A
  • AITR N/A
  • Revenue Next Year
  • ATHA N/A
  • AITR N/A
  • P/E Ratio
  • ATHA N/A
  • AITR $44.81
  • Revenue Growth
  • ATHA N/A
  • AITR N/A
  • 52 Week Low
  • ATHA $0.41
  • AITR $10.11
  • 52 Week High
  • ATHA $4.30
  • AITR $10.60
  • Technical
  • Relative Strength Index (RSI)
  • ATHA 51.78
  • AITR 70.36
  • Support Level
  • ATHA $0.60
  • AITR $10.50
  • Resistance Level
  • ATHA $0.83
  • AITR $10.59
  • Average True Range (ATR)
  • ATHA 0.10
  • AITR 0.02
  • MACD
  • ATHA 0.03
  • AITR 0.00
  • Stochastic Oscillator
  • ATHA 61.60
  • AITR 100.00

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.

About AITR AI TRANSPORTATION ACQUISITION CORP Ordinary shares

AI Transportation Acquisition Corp is a blank check company.

Share on Social Networks: